NCT00601640View on ClinicalTrials.gov

Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin

PHASE2CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

December 31, 2014

Conditions
Other Benign Neoplasm of Skin, Unspecified
Interventions
DRUG

Diclofenac Na gel

Given topically twice daily on days 1-90

DRUG

Eflornithine HCL ointment

Given topically twice daily on days 1-90

Trial Locations (3)

85258

Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea, Tucson

85723

Veterans Affairs Medical Center - Tucson, Tucson

85724-5024

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Arizona

OTHER

NCT00601640 - Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin | Biotech Hunter | Biotech Hunter